Redmile Group LLC Increased Its Stake in Immunogen INC (IMGN) by $23.52 Million as Shares Declined

ImmunoGen, Inc. (NASDAQ:IMGN) Corporate LogoBig Money Sentiment increased to 1.21 in 2018 Q2. It has change of 0.26, from 2018Q1’s 0.95. The ratio is positive due to IMGN positioning: 23 sold and 45 reduced. 23 funds amassed stakes and 59 increased stakes. Investors holded 102.59 million in 2018Q1 but now own 121.66 million shares or 18.59% more. Sei Investments Com invested in 1,200 shs or 0% of the stock. Numerixs Tech holds 0.04% of its capital in ImmunoGen, Inc. (NASDAQ:IMGN) for 18,800 shs. Ftb has 0% invested in ImmunoGen, Inc. (NASDAQ:IMGN). State Street Corp holds 0.01% or 9.00 million shs. Natixis Limited Partnership stated it has 0.01% of its capital in ImmunoGen, Inc. (NASDAQ:IMGN). Moreover, Schwab Charles Invest Mngmt has 0.01% invested in ImmunoGen, Inc. (NASDAQ:IMGN) for 765,956 shs. Ameritas Investment Partners reported 10,684 shs. United Svcs Automobile Association has invested 0% in ImmunoGen, Inc. (NASDAQ:IMGN). Hall Laurie J Trustee reported 380 shs stake. Northwestern Mutual Wealth Mgmt reported 2,000 shs stake. Teacher Retirement Sys Of Texas reported 0% of its capital in ImmunoGen, Inc. (NASDAQ:IMGN). Cwm Limited Co owns 26 shs or 0% of their US capital. Jennison Assoc Limited Com has invested 0.01% of its capital in ImmunoGen, Inc. (NASDAQ:IMGN). Daiwa Group Inc invested 0% of its capital in ImmunoGen, Inc. (NASDAQ:IMGN). Private Advisor Grp Inc Inc stated it has 0% of its capital in ImmunoGen, Inc. (NASDAQ:IMGN).

IMGN had 2 sales and 0 insider purchases since June 6, 2018. This’s net activity of $165,550. 5,851 ImmunoGen, Inc. (NASDAQ:IMGN) shs with value of $55,350 were sold by Berkenblit Anna.

In Immunogen Inc (IMGN) was rose the holdings held by Redmile Group Llc. The reduction is 26.94% according to 2018Q2 SEC filling. The company’s stock sank 9.57% while Redmile Group Llc bought 2.61M shares. At the end of 2018Q2, the hedge fund held 12.32 million shares of the health care company, valued at $119.83 million, up from 9.70 million at the end of the previous reported quarter. $884.11M is Immunogen Inc’s MC. Ticker’s shares touched $5.93 during the last trading session after 4.66% change.Currently ImmunoGen, Inc. is uptrending after 38.52% change in last November 10, 2017. IMGN has also 1.67M shares volume. The stock outperformed the S&P500 by 22.90%.

According to a filing Redmile Group Llc decreased its stake in Syneos Health Inc by 544,431 shares to 981,673 shares, valued at $46.04M in 2018Q2. The fund operates about $1.27 billion and $2.94 billion US Long portfolio. Redmile Group Llc has cut its stake in Irhythm Technologies Inc and also reduced its holding in Endologix Inc (NASDAQ:ELGX) by 1.60M shares in the quarter, for a total of 4.33M shares.

For more ImmunoGen, Inc. (NASDAQ:IMGN) news posted briefly go to: Nasdaq.com, Fool.com, Fool.com, Benzinga.com or Fool.com. The titles are as follows: “Report: Developing Opportunities within TE Connectivity, EnPro Industries, Innophos, Ameren, ImmunoGen, and ICF …” posted on November 07, 2018, “Here’s Why ImmunoGen Shares Lost 42.7% in October” on November 07, 2018, “ImmunoGen Waits to Leap “Forward”” with a publish date: November 09, 2018, “Q3 Earnings Outlook For ImmunoGen” and the last “Here’s Why ImmunoGen Fell Today” with publication date: October 22, 2018.

ImmunoGen, Inc. (NASDAQ:IMGN) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.